Skip to content
April 23, 2024

Equity.Guru

Investment information for the new generation

Search

Vivos Therapeutics

Vivos Therapeutics (VVOS.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance to Vivos’ mmRNA (modified mandibular Repositioning Nighttime Appliance) device, not to be…